Biotech
This Week’s Catalyst Calendar Summary – 1/21/12
22 January 2012 – 12:16 am PST
Comments Off
$TZYM Extends $BMY Pact, Expects Initial Phase 3 Results in Spring 2012
21 January 2012 – 12:16 am PST
Comments Off
Written by Mike Havrilla — Tranzyme Pharma (NASDAQ:TZYM) is a biopharmaceutical company focused on the development of new drugs for the treatment of chronic GI (gastrointestinal) motility disorder based on its MATCH drug discovery technology platform.
Continue reading...$CRMD Spec Bio Stock with Insider Buying and CE Mark Catalyst
19 January 2012 – 12:16 am PST
Comments Off
Written by Mike Havrilla–CorMedix (NYSEAMEX:CRMD) is focused on the development of lead product candidate NEUTROLIN
Continue reading...This Weeks Catalyst Calendar Summary 1/13/12
15 January 2012 – 12:16 am PST
Comments Off
23 January 2012 – 12:16 am PST
Comments Off